TWD 498.0
(3.11%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.45 Billion TWD | 32.36% |
2022 | 1.1 Billion TWD | 27.94% |
2021 | 861.37 Million TWD | 118.15% |
2020 | 394.84 Million TWD | 54.64% |
2019 | 255.34 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.45 Billion TWD | -0.06% |
2024 Q2 | 1.26 Billion TWD | -13.04% |
2023 Q3 | 1.53 Billion TWD | 21.1% |
2023 FY | 1.45 Billion TWD | 32.36% |
2023 Q1 | 1.21 Billion TWD | 9.96% |
2023 Q2 | 1.26 Billion TWD | 4.43% |
2023 Q4 | 1.45 Billion TWD | -4.82% |
2022 Q3 | 1 Billion TWD | 0.0% |
2022 Q4 | 1.1 Billion TWD | 9.61% |
Name | Inventory | Inventory Difference |
---|---|---|
Grape King Bio Ltd | 737.18 Million TWD | -97.866% |
Standard Chem & Pharm CO., LTD. | 1.61 Billion TWD | 9.68% |
Maywufa Company Ltd. | 257.91 Million TWD | -465.561% |
ScinoPharm Taiwan, Ltd. | 1.51 Billion TWD | 3.499% |
Lotus Pharmaceutical Co., Ltd. | 3.77 Billion TWD | 61.364% |
LIWANLI Innovation Co., Ltd. | 60.81 Million TWD | -2298.336% |
YungShin Global Holding Corporation | 2.77 Billion TWD | 47.399% |
PhytoHealth Corporation | 163.09 Million TWD | -794.38% |
SCI Pharmtech, Inc. | 529.53 Million TWD | -175.459% |
Formosa Laboratories, Inc. | 1.59 Billion TWD | 8.69% |
Bora Pharmaceuticals Co., LTD. | 2.15 Billion TWD | 32.349% |